Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Songha Night in mild to moderate insomnia
NCT02183714Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 1998
- Primary completion
- Dec 1998
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Insomnia comparing Songha Night with Placebo (2 arms). Primary endpoint: Change in sleep quality on a visual analogue scale (VAS) at 5 weeks. Started May 1998; status: completed.
02
Drugs
Songha Night
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02183714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183714.